Many expectant moms are unaware of the dangers of cannabis use.

Kimberly-Clark has agreed to acquire Johnson & Johnson (J&J) consumer health spinout Kenvue for $48.7bn. One of America’s ...

Tylenol faces scrutiny over pregnancy use and autism links, despite scientific bodies finding no firm evidence. While ...

Parents deserve honest, evidence-based communication that acknowledges the many factors that contribute to a given child’s ...

The news comes as Kenvue maker Tylenol has been embroiled in litigation surrounding the alleged relationship between Tylenol ...

A £30 billion takeover shakes up the consumer health sector as Kimberly-Clark, the maker of Huggies nappies, prepares to ...

The recent publicity could allow the company to get a good deal on Kenvue, which makes Tylenol, Band-Aids, and other ...

Irving-based Kimberly-Clark snaps up Tylenol maker Kenvue in a cash-and-stock blockbuster, uniting Kleenex, Huggies, and Band ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.

Kimberly-Clark Corp, the company behind popular brands like Kleenex and Huggies, has announced its plan to acquire Kenvue Inc ...

Kimberly-Clark said the combination would create a company with $32 billion in revenue and allow it to surpass Unilever Plc ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...